{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:11:22Z","timestamp":1791619882336,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04364-y","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:44:03Z","timestamp":1753544643000},"page":"745-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Orbital MRI and clinical activity score for predicting steroid treatment response in moderate-to-severe Graves\u2019 orbitopathy"],"prefix":"10.1007","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-330X","authenticated-orcid":false,"given":"Bet\u00fcl Yi\u011fit","family":"Yal\u00e7\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-1955","authenticated-orcid":false,"given":"G\u00f6rkem","family":"Durak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8636-8700","authenticated-orcid":false,"given":"Gamze Bilik","family":"Oyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8715-1893","authenticated-orcid":false,"given":"Mehmet","family":"Barburo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-7326","authenticated-orcid":false,"given":"\u00dcmm\u00fc","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6473","authenticated-orcid":false,"given":"H\u00fclya","family":"Haci\u015fahino\u011fullar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-944X","authenticated-orcid":false,"given":"Nurdan","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-4764","authenticated-orcid":false,"given":"\u00d6zlem Soyluk","family":"Sel\u00e7ukbiricik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-1193","authenticated-orcid":false,"given":"Ay\u015fe Kubat","family":"\u00dcz\u00fcm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-5237","authenticated-orcid":false,"given":"G\u00fcl\u015fah Yenid\u00fcnya","family":"Yal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"4364_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.survophthal.2009.06.009","volume":"55","author":"VM Naik","year":"2010","unstructured":"V.M. Naik, M.N. Naik, R.A. Goldberg, T.J. Smith, R.S. Douglas, Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv. Ophthalmol. 55, 215\u2013226 (2010). https:\/\/doi.org\/10.1016\/j.survophthal.2009.06.009.","journal-title":"Surv. Ophthalmol."},{"key":"4364_CR2","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"L. Bartalena, G.J. Kahaly, L. Baldeschi, C.M. Dayan, A. Eckstein, C. Marcocci et al., The 2021 European group on Graves\u2019 orbitopathy clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur. J. Endocrinol. 185, G43\u2013G67 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0479.","journal-title":"Eur. J. Endocrinol."},{"key":"4364_CR3","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","volume":"105","author":"GJ Kahaly","year":"2020","unstructured":"G.J. Kahaly, Management of Graves\u2019 thyroidal and extrathyroidal disease: an update. J. Clin. Endocrinol. Metab. 105, 3704\u20133720 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa646.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4364_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","volume":"45","author":"EJ Neag","year":"2022","unstructured":"E.J. Neag, T.J. Smith, 2021 update on thyroid-associated ophthalmopathy. J. Endocrinol. Invest. 45, 235\u2013259 (2022). https:\/\/doi.org\/10.1007\/s40618-021-01663-9.","journal-title":"J. Endocrinol. Invest."},{"key":"4364_CR5","doi-asserted-by":"publisher","first-page":"615993","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"L. Bartalena, E. Piantanida, D. Gallo, A. Lai, M.L. Tanda, Epidemiology, natural history, risk factors and prevention of Graves\u2019 orbitopathy. Front. Endocrinol. 11, 615993 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.615993.","journal-title":"Front. Endocrinol."},{"key":"4364_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1292519","volume":"14","author":"H Zhang","year":"2023","unstructured":"H. Zhang, J. Fan, J. Qu, Q. Han, H. Zhou, X. Song, Predictive markers for anti-inflammatory treatment response in thyroid eye disease. Front. Endocrinol. 14, 1292519 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1292519.","journal-title":"Front. Endocrinol."},{"key":"4364_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/187152211795495689","volume":"11","author":"S Zang","year":"2011","unstructured":"S. Zang, G.J. Kahaly, Steroids and the immune response in Graves\u2019 orbitopathy. Immunol. Endocr. Metab. Agents Med. Chem. 11, 90\u201398 (2011). https:\/\/doi.org\/10.2174\/187152211795495689.","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"key":"4364_CR8","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/OPTH.S118555","volume":"10","author":"T Tsirouki","year":"2016","unstructured":"T. Tsirouki, A. Bargiota, S. Tigas, A. Vasileiou, E. Kapsalaki, Z. Giotaki et al., Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves\u2019 orbitopathy. Clin. Ophthalmol. 10, 2277\u20132289 (2016). https:\/\/doi.org\/10.2147\/OPTH.S118555.","journal-title":"Clin. Ophthalmol."},{"key":"4364_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.5603\/EP.a2022.0040","volume":"73","author":"M Nowak","year":"2022","unstructured":"M. Nowak, B. Marek, B. Kos-Kud\u0142a, L. Siemi\u0144ska, M. Londzin-Olesik, J. G\u0142ogowska-Szel\u0105g et al., Optimization of the treatment of moderate-to-severe and active thyroid orbitopathy considering the EUGOGO recommendations. Endokrynol. Pol. 73, 756\u2013777 (2022). https:\/\/doi.org\/10.5603\/EP.a2022.0040.","journal-title":"Endokrynol. Pol."},{"key":"4364_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"M.P. Mourits, L. Koornneef, W.M. Wiersinga, M.F. Prummel, A. Berghout, R. van der Gaag, Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73, 639\u2013644 (1989). https:\/\/doi.org\/10.1136\/bjo.73.8.639.","journal-title":"Br. J. Ophthalmol."},{"key":"4364_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","volume":"55","author":"AJ Dickinson","year":"2001","unstructured":"A.J. Dickinson, P. Perros, Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin. Endocrinol. 55, 283\u2013303 (2001). https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01349.x.","journal-title":"Clin. Endocrinol."},{"key":"4364_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1507\/endocrj.K10E-156","volume":"57","author":"S Tachibana","year":"2010","unstructured":"S. Tachibana, T. Murakami, H. Noguchi, Y. Noguchi, A. Nakashima, Y. Ohyabu et al., Orbital magnetic resonance imaging combined with clinical activity score improves detection of disease activity and prediction of immunosuppressive response in Graves\u2019 ophthalmopathy. Endocr. J. 57, 853\u2013861 (2010). https:\/\/doi.org\/10.1507\/endocrj.K10E-156.","journal-title":"Endocr. J."},{"key":"4364_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00234-009-0590-z","volume":"52","author":"EC Kirsch","year":"2010","unstructured":"E.C. Kirsch, A.H. Kaim, M.G. De Oliveira, G. von Arx, Signal-intensity ratio on orbital MRI-TIRM correlates with clinical activity score and may predict therapy response in Graves\u2019 orbitopathy: a 1.5 T pilot study. Neuroradiology 52, 91\u201397 (2010). https:\/\/doi.org\/10.1007\/s00234-009-0590-z.","journal-title":"Neuroradiology"},{"key":"4364_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.sjopt.2012.07.006","volume":"26","author":"MP Rabinowitz","year":"2012","unstructured":"M.P. Rabinowitz, J.R. Carrasco, Update on advanced imaging options for thyroid-associated orbitopathy. Saudi J. Ophthalmol. 26, 385\u2013392 (2012). https:\/\/doi.org\/10.1016\/j.sjopt.2012.07.006.","journal-title":"Saudi J. Ophthalmol."},{"key":"4364_CR15","doi-asserted-by":"publisher","first-page":"368536","DOI":"10.1155\/2012\/368536","volume":"2012","author":"S El-Kaissi","year":"2012","unstructured":"S. El-Kaissi, J.R. Wall, Determinants of extra-ocular muscle volume in patients with Graves\u2019 disease. J. Thyroid. Res. 2012, 368536 (2012). https:\/\/doi.org\/10.1155\/2012\/368536.","journal-title":"J. Thyroid. Res."},{"key":"4364_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10384-014-0365-x","volume":"59","author":"T Higashiyama","year":"2015","unstructured":"T. Higashiyama, Y. Nishida, K. Morino, S. Matsumoto, E. Umeda, M. Ohji et al., Use of MRI signal intensity of extra-ocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy. Jpn. J. Ophthalmol. 59, 124\u2013130 (2015). https:\/\/doi.org\/10.1007\/s10384-014-0365-x.","journal-title":"Jpn. J. Ophthalmol."},{"key":"4364_CR17","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.4158\/EP-2019-0133","volume":"25","author":"M Zhou","year":"2019","unstructured":"M. Zhou, L. Shen, Q. Jiao, L. Ye, Y. Zhou, W. Zhu et al., Role of magnetic resonance imaging in the assessment of active thyroid-associated ophthalmopathy patients with long disease duration. Endocr. Pract. 25, 1268\u20131278 (2019). https:\/\/doi.org\/10.4158\/EP-2019-0133.","journal-title":"Endocr. Pract."},{"key":"4364_CR18","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 5.0. 27 Nov 2017. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm. (Accessed 14 May 2025)"},{"key":"4364_CR19","doi-asserted-by":"publisher","first-page":"e220260","DOI":"10.1530\/EC-22-0260","volume":"11","author":"X Zhang","year":"2022","unstructured":"X. Zhang et al., The correlation of the neutrophil\u2013lymphocyte ratio to clinical and imaging parameters in patients with thyroid eye disease. Endocr. Connect. 11, e220260 (2022).","journal-title":"Endocr. Connect."},{"key":"4364_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00417-009-1214-3","volume":"248","author":"KT Johnson","year":"2010","unstructured":"K.T. Johnson, M.R. Vagefi, S. Ugradar et al., A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves\u2019 orbitopathy. Graefes Arch. Clin. Exp. Ophthalmol. 248, 103\u2013109 (2010). https:\/\/doi.org\/10.1007\/s00417-009-1214-3.","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"4364_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1210\/clinem\/dgad637","volume":"109","author":"RS Douglas","year":"2024","unstructured":"R.S. Douglas, A. Patel, L. Crouse et al., Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity. J. Clin. Endocrinol. Metab. 109, 24\u201335 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgad637.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4364_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10792-022-02537-6","volume":"43","author":"X Li","year":"2023","unstructured":"X. Li, S. Li, W. Fan, A.C. Rokohl, S. Ju, X. Ju, Y. Guo, L.M. Heindl, Recent advances in Graves ophthalmopathy medical therapy: a comprehensive literature review. Int. Ophthalmol. 43(4), 1437\u20131449 (2023). https:\/\/doi.org\/10.1007\/s10792-022-02537-6.","journal-title":"Int. Ophthalmol."},{"issue":"4","key":"4364_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1089\/thy.2024.0629","volume":"35","author":"N Baczewska","year":"2024","unstructured":"N. Baczewska, O. Alexopoulou, S.M. Constantinescu et al., Factors associated with response to intravenous glucocorticoids in active moderate-to-severe thyroid eye disease. Thyroid 35(4), 424\u2013432 (2024). https:\/\/doi.org\/10.1089\/thy.2024.0629.","journal-title":"Thyroid"},{"key":"4364_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/diagnostics15030388","volume":"15","author":"W Zhou","year":"2025","unstructured":"W. Zhou, Y. Song, J. Shi, T. Li, The value of MRI and radiomics for the diagnostic evaluation of thyroid-associated ophthalmopathy. Diagnostics 15, 388 (2025). https:\/\/doi.org\/10.3390\/diagnostics15030388.","journal-title":"Diagnostics"},{"key":"4364_CR25","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1210\/jc.2012-2389","volume":"97","author":"L Bartalena","year":"2012","unstructured":"L. Bartalena, G.E. Krassas, W. Wiersinga et al., Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate-to-severe Graves\u2019 orbitopathy. J. Clin. Endocrinol. Metab. 97, 4454\u20134463 (2012). https:\/\/doi.org\/10.1210\/jc.2012-2389.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4364_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/jc.2010-1962","volume":"96","author":"S Zang","year":"2011","unstructured":"S. Zang, K.A. Ponto, G.J. Kahaly, Intravenous glucocorticoids for Graves\u2019 orbitopathy: efficacy and morbidity. J. Clin. Endocrinol. Metab. 96, 320\u2013332 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1962.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4364_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00234-014-1332-4","volume":"56","author":"F Tortora","year":"2014","unstructured":"F. Tortora, M. Prudente, M. Cirillo et al., Diagnostic accuracy of short-tau inversion-recovery MRI before and after prednisone therapy in Graves\u2019 ophthalmopathy. Neuroradiology 56, 353\u2013361 (2014). https:\/\/doi.org\/10.1007\/s00234-014-1332-4.","journal-title":"Neuroradiology"},{"key":"4364_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"M.P. Mourits, M.F. Prummel, W.M. Wiersinga, L. Koornneef, Clinical activity score as a guide in the management of Graves\u2019 ophthalmopathy. Clin. Endocrinol. 47, 9\u201314 (1997). https:\/\/doi.org\/10.1046\/j.1365-2265.1997.2331047.x.","journal-title":"Clin. Endocrinol."},{"key":"4364_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/jc.2009-0376","volume":"94","author":"H Stiebel-Kalish","year":"2009","unstructured":"H. Stiebel-Kalish, E. Robenshtok, M. Hasanreisoglu et al., Treatment modalities for Graves\u2019 ophthalmopathy: systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 94, 268\u2013276 (2009). https:\/\/doi.org\/10.1210\/jc.2009-0376.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4364_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/197140091302600509","volume":"26","author":"F Tortora","year":"2013","unstructured":"F. Tortora, M. Cirillo, M. Ferrara et al., Disease activity in Graves\u2019 ophthalmopathy: diagnosis with orbital MRI and correlation with clinical activity score. Neuroradiol. J. 26, 555\u2013564 (2013). https:\/\/doi.org\/10.1177\/197140091302600509.","journal-title":"Neuroradiol. J."},{"key":"4364_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejrad.2005.03.027","volume":"56","author":"EJ Mayer","year":"2005","unstructured":"E.J. Mayer, D.L. Fox, G. Herdman et al., Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Eur. J. Radiol. 56, 20\u201324 (2005). https:\/\/doi.org\/10.1016\/j.ejrad.2005.03.027.","journal-title":"Eur. J. Radiol."},{"key":"4364_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.31348\/2023\/10","volume":"79","author":"M Karhanov\u00e1","year":"2023","unstructured":"M. Karhanov\u00e1, J. \u010civrn\u00fd, J. Kalitov\u00e1 et al., Computed tomography and MRI of the orbit in thyroid-associated orbitopathy: experience from practice. Cesk. Slov. Oftalmol. 79, 283\u2013292 (2023). https:\/\/doi.org\/10.31348\/2023\/10.","journal-title":"Cesk. Slov. Oftalmol."},{"key":"4364_CR33","first-page":"44","volume":"13","author":"A Majos","year":"2007","unstructured":"A. Majos, M. Paj\u0105k, M. Elgalal, P. Grzelak, L. Stefa\u0144czyk, MRI evaluation of disease activity in Graves\u2019 ophthalmopathy: T2 time and signal intensity of extra-ocular muscles. Med. Sci. Monit. 13, 44\u201348 (2007).","journal-title":"Med. Sci. Monit."},{"key":"4364_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38640-5","volume":"9","author":"M Ito","year":"2019","unstructured":"M. Ito, Y. Takahashi, E. Katsuda et al., Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease. Sci. Rep. 9, 2027 (2019). https:\/\/doi.org\/10.1038\/s41598-019-38640-5.","journal-title":"Sci. Rep."},{"key":"4364_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1507\/endocrine1927.68.3_143","volume":"68","author":"M Sato","year":"1992","unstructured":"M. Sato, Y. Hiromatsu, K. Tanaka et al., Prediction for effectiveness of steroid pulse therapy by MRI in Graves\u2019 ophthalmopathy. Nihon Naibunpi Gakkai Zasshi 68, 143\u2013153 (1992). https:\/\/doi.org\/10.1507\/endocrine1927.68.3_143.","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"key":"4364_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12020-020-02367-5","volume":"70","author":"H Hu","year":"2020","unstructured":"H. Hu, X.Q. Xu, L. Chen, W. Chen, Q. Wu, H.H. Chen, H. Zhu, H.B. Shi, F.Y. Wu, Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Endocrine 70, 372\u2013379 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02367-5.","journal-title":"Endocrine"},{"key":"4364_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/thy.1992.2.299","volume":"2","author":"Y Hiromatsu","year":"1992","unstructured":"Y. Hiromatsu, K. Kojima, N. Ishisaka, K. Tanaka, M. Sato, K. Nonaka et al., Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 2, 299\u2013305 (1992). https:\/\/doi.org\/10.1089\/thy.1992.2.299.","journal-title":"Thyroid"},{"key":"4364_CR38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/jmri.28088","volume":"56","author":"H Hu","year":"2022","unstructured":"H. Hu, L. Chen, J.L. Zhang, W. Chen, H.H. Chen, H. Liu, H.B. Shi, F.Y. Wu, X.Q. Xu, T2-weighted MR imaging-derived radiomics for pretreatment determination of therapeutic response to glucocorticoid in patients with thyroid-associated ophthalmopathy: comparison with semiquantitative evaluation. J. Magn. Reson. Imaging 56, 862\u2013872 (2022). https:\/\/doi.org\/10.1002\/jmri.28088.","journal-title":"J. Magn. Reson. Imaging"},{"key":"4364_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/thy.1995.5.185","volume":"5","author":"CI Utech","year":"1995","unstructured":"C.I. Utech, U. Khatibnia, P.F. Winter et al., MR T2 relaxation time for assessing retrobulbar inflammation in Graves\u2019 ophthalmopathy. Thyroid 5, 185\u2013193 (1995). https:\/\/doi.org\/10.1089\/thy.1995.5.185.","journal-title":"Thyroid"},{"key":"4364_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/eye.1994.126","volume":"8","author":"HB Hoh","year":"1994","unstructured":"H.B. Hoh, R.D. Laitt, C. Wakeley et al., The STIR-sequence MRI in the assessment of extra-ocular muscles in thyroid eye disease. Eye 8, 506\u2013510 (1994). https:\/\/doi.org\/10.1038\/eye.1994.126.","journal-title":"Eye"},{"key":"4364_CR41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/OPTH.S105096","volume":"10","author":"T Higashiyama","year":"2016","unstructured":"T. Higashiyama, Y. Nishida, M. Ohji, Relationship between magnetic resonance imaging signal intensity and volume of extra-ocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy. Clin. Ophthalmol. 10, 721\u2013729 (2016). https:\/\/doi.org\/10.2147\/OPTH.S105096.","journal-title":"Clin. Ophthalmol."},{"key":"4364_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/eye.2001.102","volume":"15","author":"E Mayer","year":"2001","unstructured":"E. Mayer, G. Herdman, C. Burnett et al., Serial STIR MRI correlates with clinical activity score in thyroid eye disease. Eye 15, 313\u2013318 (2001). https:\/\/doi.org\/10.1038\/eye.2001.102.","journal-title":"Eye"},{"key":"4364_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112136","volume":"188","author":"D Xia","year":"2025","unstructured":"D. Xia, S.P. Chew, H. Zhang et al., Contrast-enhanced orbital MRI for activity assessment and treatment response prediction in thyroid eye disease. Eur. J. Radiol. 188, 112136 (2025). https:\/\/doi.org\/10.1016\/j.ejrad.2025.112136.","journal-title":"Eur. J. Radiol."},{"key":"4364_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00234-002-0930-8","volume":"45","author":"K Ayd\u0131n","year":"2003","unstructured":"K. Ayd\u0131n et al., A new MRI method for the quantitative evaluation of extra-ocular muscle size in thyroid ophthalmopathy. Neuroradiology 45, 184\u2013187 (2003). https:\/\/doi.org\/10.1007\/s00234-002-0930-8.","journal-title":"Neuroradiology"},{"key":"4364_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04792-2","volume":"22","author":"Q Wu","year":"2024","unstructured":"Q. Wu, H. Hu, W. Chen et al., Whole-orbit radiomics: machine learning-based multi- and fused-region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease. J. Transl. Med. 22, 81 (2024). https:\/\/doi.org\/10.1186\/s12967-023-04792-2.","journal-title":"J. Transl. Med."},{"key":"4364_CR46","doi-asserted-by":"publisher","first-page":"e240122","DOI":"10.1530\/ETJ-24-0122","volume":"13","author":"H Zhang","year":"2024","unstructured":"H. Zhang, S. Yang, H. Zhao et al., Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease. Eur. Thyroid. J. 13, e240122 (2024). https:\/\/doi.org\/10.1530\/ETJ-24-0122.","journal-title":"Eur. Thyroid. J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04364-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:07:05Z","timestamp":1761736025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04364-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4364"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04364-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study involving human participants was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the Istanbul University, Istanbul Faculty of Medicine Ethics Committee (Approval date: November 21, 2023; Protocol number: 2261474).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was not required due to the retrospective nature of the study and the use of anonymized patient data, as approved by the institutional ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study does not contain any individual person\u2019s data in any form (including images, videos, or identifiable details), and therefore consent to publish was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}